•  
SSL
0item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.
  • Bedaquiline; TMC207; R207910 Bedaquiline; TMC207; R207910

Bedaquiline; TMC207; R207910

Quick Overview

CAS No.: 843663-66-1
Catalog No.: 141027
Purity: 95%
MF: C32H31BrN2O2
MW: 555.516
Storage: Room temperature
  • Size
    Price
    Stock
    Estimated Shipping Time
$100.00
Download MSDS         Download COA&Spectra


Details

Bedaquiline, a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.


In Vitro
Bedaquiline inhibits the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L[1]. Among slowly growing mycobacteria (SGM), bedaquiline exhibits the highest activity against Mycobacterium avium with MIC50 and MIC90 values of 0.03 and 16 mg/L, respectively. Among rapidly growing mycobacteria (RGM), Mycobacterium abscessus subsp. abscessus (M. abscessus) and Mycobacterium abscessus subsp. massiliense (M. massiliense) seem more susceptible to bedaquiline than Mycobacterium fortuitum, with MIC50 and MIC90 values of 0.13 and >16 mg/L, respectively, for both species. Bedaquiline also shows moderate in vitro activity against NTM species[2]. Bedaquiline has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis[3].


References
[1]. Jang JC, et al. Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis. J Microbiol. 2017 Apr 20.
[2]. Pang Y, et al. In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. Antimicrob Agents Chemother. 2017 Apr 24;61(5).
[3]. Chahine EB, et al. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother. 2014 Jan;48(1):107-15.
  1. Be the first to review this product

Write Your Own Review

[profiler]
Memory usage: real: 45350912, emalloc: 43680008
Code ProfilerTimeCntEmallocRealMem